Literature DB >> 6186560

Effect of interferon on encephalomyocarditis virus infection of cultured mouse pancreatic B cells.

G L Wilson, S C Bellomo, J E Craighead.   

Abstract

The M variant of encephalomyocarditis virus (EMC) produces a disease similar to human insulin-dependent diabetes mellitus in some but not all strains of mice. This diabetogenic M variant was found to induce fivefold more interferon than non-diabetogenic strains of EMC in cultures of mouse L 929 fibroblasts. When interferon induced by the M variant was added to monolayers of B cells from both diabetes-'susceptible' CD-1 mice and 'resistant' C57 bl/6 mice before EMC infection, B cell damage and virus replication were delayed. In addition, viral production in B cell cultures from C57 bl/6 mice was reduced five- to tenfold. A similar effect was not found when cultures from CD-1 mice were treated with interferon. Thus, interferon might play an important role in modulating the severity of the initial infection of B cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6186560     DOI: 10.1007/bf00275945

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  Virus-induced diabetes mellitus: VIII. Passage of encephalomyocarditis virus and severity of diabetes in susceptible and resistant strains of mice.

Authors:  J Yoon; T Onodera; A L Notkins
Journal:  J Gen Virol       Date:  1977-11       Impact factor: 3.891

2.  Pathogenicity of the M and E variants of the encephalomyocarditis (EMC) virus. I. Myocardiotropic and neurotropic properties.

Authors:  J E Craighead
Journal:  Am J Pathol       Date:  1966-02       Impact factor: 4.307

3.  Encephalomyocarditis virus infection of cultured murine pancreatic beta-cells.

Authors:  G L Wilson; B J D'Andrea; S C Bellomo; J E Craighead
Journal:  Nature       Date:  1980-05-08       Impact factor: 49.962

4.  Susceptibility to diabetogenic virus: host versus pancreatic factors.

Authors:  D C Dafoe; A Naji; S A Plotkin; C F Barker
Journal:  J Surg Res       Date:  1980-04       Impact factor: 2.192

5.  Virus induced diabetes and the immune system. II -- Evidence for an immune pathogenesis of the acute phase of diabetes.

Authors:  F K Jansen; O Thurneyssen; H Müntefering
Journal:  Biomedicine       Date:  1979-02

6.  Lesions of the islets of Langerhans in encephalomyocarditis virus-infected mice with diabetes mellitus-like disease. I. Acute lesions.

Authors:  J E Craighead; R E Kanich; J B Kessler
Journal:  Am J Pathol       Date:  1974-02       Impact factor: 4.307

7.  Insulin immunoassay by back-titration; some characteristics of the technic and the insulin precipitant action of alcohol.

Authors:  P H Wright; D R Makulu; D Vichick; K E Sussman
Journal:  Diabetes       Date:  1971-01       Impact factor: 9.461

8.  Effect of genetic obesity in mice on the induction of diabetes by encephalomyocarditis virus.

Authors:  B J D'Andrea; G L Wilson; J E Craighead
Journal:  Diabetes       Date:  1981-05       Impact factor: 9.461

9.  Virus-induced diabetes mellitus. VI. Genetically determined host differences in the replicating of encephalomyocarditis virus in pancreatic beta cells.

Authors:  J W Yoon; A L Notkins
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus.

Authors:  J W Yoon; P R McClintock; T Onodera; A L Notkins
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  2 in total

1.  Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.

Authors:  V A Koivisto; A Aro; K Cantell; M Haataja; J Huttunen; S L Karonen; P Mustajoki; R Pelkonen; P Seppälä
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

2.  Effect of human lymphoblastoid interferon on insulin synthesis and secretion in isolated human pancreatic islets.

Authors:  C J Rhodes; K W Taylor
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.